Work

Rituximab (anti-CD20 monoclonal antibody) therapy for progressive intermediate-grade non-Hodgkin’s lymphoma after high-dose therapy and autologous peripheral stem cell transplantation

Year: 1999

Type: article

Source: Bone Marrow Transplantation

DOI: 10.1038/sj.bmt.1701944

Authors: DE Tsai, HCF Moore, CL Hardy, DL Porter, EY Loh, DJ Vaughn, S Luger, SJ Schuster, EA Stadtmauer

Institution: University of Pennsylvania

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2314700752

FWCI: 2.722

Cites:

Cited by: 35

Related to: 10